Showing results (31-40 of 259) with videos related to
Sort By:
Pageof 26
Behavioural Brain Research|June 24, 2008
Molecular biology of 5-HT receptorsJason Hannon, Daniel HoyerCurrent Drug Targets|January 2, 2016
Astrocytes: Adhesion Molecules and ImmunomodulationShane Liddelow, Daniel HoyerPNAS Nexus|February 7, 2024
The characteristic time scale of cultural evolutionTobias Wand, Daniel HoyerPsychopharmacology|January 26, 2005
Differential sensitivity to the motor and hypothermic effects of the GABA B receptor agonist baclofen in various mouse strainsLaura H Jacobson, John F CryanChemistry & Biodiversity|November 20, 2012
Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter SeebachDaniel Hoyer, Tamas BartfaiDrug Discovery Today. Therapeutic Strategies|April 15, 2020
RNA interference as a therapeutic strategy for treating CNS disordersDaniel Hoyer, Kumlesh K DevJournal of Medicinal Chemistry|August 23, 2013
Identification of a novel series of orexin receptor antagonists with a distinct effect on sleep architecture for the treatment of insomniaClaudia Betschart, Samuel Hintermann, Dirk Behnke, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 17, 2003
Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophsDavide Cervia, Dominique Fehlmann, Daniel HoyerBioorganic & Medicinal Chemistry Letters|November 3, 2015
Discovery of 1H-pyrazolo[3,4-b]pyridines as potent dual orexin receptor antagonists (DORAs)Dirk Behnke, Simona Cotesta, Samuel Hintermann, et al.Psychopharmacology|March 8, 2017
A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatmentJose M Palacios, Angel Pazos, Daniel HoyerPageof 26